TY - JOUR
T1 - Stereotactic radiosurgery versus active surveillance for incidental, convexity meningiomas
T2 - a matched cohort analysis from the IMPASSE study
AU - Pikis, Stylianos
AU - Mantziaris, Georgios
AU - Islim, Abdurrahman I
AU - Peker, Selcuk
AU - Samanci, Yavuz
AU - Nabeel, Ahmed M
AU - Reda, Wael A
AU - Abdelkarim, Khaled
AU - El-Shehaby, Amr M N
AU - Tawadros, Sameh R
AU - Emad, Reem M
AU - Delabar, Violaine
AU - Mathieu, David
AU - Lee, Cheng-Chia
AU - Yang, Huai-Che
AU - Licsak, Roman
AU - Hanuska, Jaromir
AU - Alvarez, Roberto Martinez
AU - Patel, Dev N
AU - Kondziolka, Douglas
AU - Bernstein, Kenneth
AU - Moreno, Nuria Martinez
AU - Tripathi, Manjul
AU - Speckter, Herwin
AU - Albert, Camilo
AU - Bowden, Greg N
AU - Benveniste, Ronald J
AU - Lunsford, Dade L
AU - Jenkinson, Michael D
AU - Sheehan, Jason
N1 - © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/3
Y1 - 2022/3
N2 - BACKGROUND: The optimal treatment strategy of asymptomatic, convexity meningiomas, remains unclear.OBJECTIVE: The purpose of this study was to define the safety and efficacy of stereotactic radiosurgery (SRS) in the management of patients with asymptomatic convexity meningiomas.METHODS: Data of SRS-treated patients from 14 participating centers and patients managed conservatively for an asymptomatic, convexity-located meningioma were compared. Local tumor control rate and development of new neurologic deficits were evaluated in the active surveillance and in the SRS-treated cohorts.RESULTS: In the unmatched cohorts, there were 99 SRS-treated patients and 140 patients managed conservatively for an asymptomatic, convexity meningioma. Following propensity score matching for age, there were 98 patients in each cohort. In the matched cohorts, tumor control was achieved in 99% of SRS-treated, and in 69.4% of conservatively managed patients (p < 0.001). New neurological deficits occurred in 2.0% of patients in each of the matched cohorts (p = 1.00). Increasing age was predictive of tumor growth [(OR 1.1; 95% CI (1.04 - 1.2), (p < 0.001)].CONCLUSION: This is one of the first reports to suggest that SRS is a low risk and effective treatment strategy for asymptomatic incidentally discovered convexity meningiomas. In this study, tumor control was achieved in significantly more patients after radiosurgery compared to those managed with active surveillance. SRS may be offered at diagnosis of an asymptomatic convexity meningioma and should be recommended when meningioma growth is noted on follow-up.
AB - BACKGROUND: The optimal treatment strategy of asymptomatic, convexity meningiomas, remains unclear.OBJECTIVE: The purpose of this study was to define the safety and efficacy of stereotactic radiosurgery (SRS) in the management of patients with asymptomatic convexity meningiomas.METHODS: Data of SRS-treated patients from 14 participating centers and patients managed conservatively for an asymptomatic, convexity-located meningioma were compared. Local tumor control rate and development of new neurologic deficits were evaluated in the active surveillance and in the SRS-treated cohorts.RESULTS: In the unmatched cohorts, there were 99 SRS-treated patients and 140 patients managed conservatively for an asymptomatic, convexity meningioma. Following propensity score matching for age, there were 98 patients in each cohort. In the matched cohorts, tumor control was achieved in 99% of SRS-treated, and in 69.4% of conservatively managed patients (p < 0.001). New neurological deficits occurred in 2.0% of patients in each of the matched cohorts (p = 1.00). Increasing age was predictive of tumor growth [(OR 1.1; 95% CI (1.04 - 1.2), (p < 0.001)].CONCLUSION: This is one of the first reports to suggest that SRS is a low risk and effective treatment strategy for asymptomatic incidentally discovered convexity meningiomas. In this study, tumor control was achieved in significantly more patients after radiosurgery compared to those managed with active surveillance. SRS may be offered at diagnosis of an asymptomatic convexity meningioma and should be recommended when meningioma growth is noted on follow-up.
KW - Cohort Studies
KW - Follow-Up Studies
KW - Humans
KW - Meningeal Neoplasms/epidemiology
KW - Meningioma/pathology
KW - Radiosurgery/adverse effects
KW - Retrospective Studies
KW - Treatment Outcome
KW - Watchful Waiting
U2 - 10.1007/s11060-022-03953-5
DO - 10.1007/s11060-022-03953-5
M3 - Article
C2 - 35092547
SN - 1573-7373
VL - 157
SP - 121
EP - 128
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 1
ER -